These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17325841)

  • 21. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
    Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M
    Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide for the treatment of severe intestinal bleeding.
    Alberto SF; Felix J; de Deus J
    Endoscopy; 2008 Sep; 40(9):788; author reply 789. PubMed ID: 18773348
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide therapy induces response in relapsed mantle cell lymphoma.
    Damaj G; Lefrère F; Delarue R; Varet B; Furman R; Hermine O
    Leukemia; 2003 Sep; 17(9):1914-5. PubMed ID: 12970798
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).
    Gonsalves WI; Buadi FK; Kumar SK
    Eur J Haematol; 2018 Feb; 100(2):215-217. PubMed ID: 29064593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial.
    Musto P
    Cancer; 2007 Mar; 109(6):1211-2; author reply 1212. PubMed ID: 17279582
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog.
    Jarvi K; Roebuck DJ; Sebire NJ; Lindley K; Shah N; Salomon J; Curry JI
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):593-7. PubMed ID: 18493217
    [No Abstract]   [Full Text] [Related]  

  • 28. Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia.
    Johnston RE; Abdalla SH
    Leuk Lymphoma; 2002 Feb; 43(2):351-4. PubMed ID: 11999568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thalidomide therapy for gastrointestinal angiodysplasia].
    Bélard E; Foss CH; Christensen LA; Schmidt P; Nøjgaard C
    Ugeskr Laeger; 2009 Nov; 171(47):3454-5. PubMed ID: 19925735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 31. Resident rounds part III: plasma cell leukemia with initial cutaneous presentation.
    Fabbro SK; Kaffenberger BH
    J Drugs Dermatol; 2014 Aug; 13(8):994-5. PubMed ID: 25271340
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent thalidomide and radiation therapy for extensive arterio-venous malformations.
    Blinc A; Golli T; Vodnik AC; Zver S
    Thromb Haemost; 2008 Jan; 99(1):235-7. PubMed ID: 18217160
    [No Abstract]   [Full Text] [Related]  

  • 33. Thalidomide for the treatment of acute myeloid leukemia.
    Steins MB; Bieker R; Padró T; Kessler T; Kienast J; Berdel WE; Mesters RM
    Leuk Lymphoma; 2003 Sep; 44(9):1489-93. PubMed ID: 14565649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
    Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide--a treatment for cancer?
    Mayo Clin Health Lett; 2000 Jun; 18(6):4. PubMed ID: 10868128
    [No Abstract]   [Full Text] [Related]  

  • 36. PSA response to thalidomide in patients with advanced prostate cancer.
    Leibowitz R; Tucker SJ
    Oncology (Williston Park); 2002 Sep; 16(9):1146, 1148. PubMed ID: 12380944
    [No Abstract]   [Full Text] [Related]  

  • 37. Thalidomide in POEMS syndrome: case report.
    Sinisalo M; Hietaharju A; Sauranen J; Wirta O
    Am J Hematol; 2004 May; 76(1):66-8. PubMed ID: 15114600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide in angiodysplasia-related bleeding.
    Boey JP; Hahn U; Sagheer S; McRae SJ
    Intern Med J; 2015 Sep; 45(9):972-6. PubMed ID: 26332623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide shows promise as cancer treatment.
    Health News; 2000 Jan; 6(1):8. PubMed ID: 11019665
    [No Abstract]   [Full Text] [Related]  

  • 40. Thalidomide in the treatment of cancer cachexia.
    Tassinari D; Santelmo C; Tombesi P; Sartori S
    J Palliat Care; 2008; 24(3):187-9. PubMed ID: 18942570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.